s6y
Company name or ticker
Search
Evoke Pharma Inc
DEF 14A
Definitive proxy statements
Filed
Wednesday, April 10, 2024
Period
Apr 10, 2024
Accession number
0000950170-24-043306
Documents
DEF 14A
DEF 14A
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
EX-101.SCH
On sec.gov
Filing index
All files
Complete submission text
SGML header